Research Article

The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study

Table 3

The eight-item SF-36 scores in LT and KT patients 12 weeks (T12) after the end of DAA therapy. Data are expressed as (SD).

SF-36 componentsLT patients
KT patients

Physical function0.02
Role-physical0.02
Bodily pain0.4
General health0.2
Vitality0.03
Social function0.2
Role-emotional<0.001
Mental health0.1

LT: liver transplant; KT: kidney transplant.